Senior insider sale
Chief Development Officer at OLEMA PHARMACEUTICALS, INC. — senior position signals high conviction
$1.84M
61K shares
What this filing means
MYLES DAVID C. plans to sell 61K shares of OLEMA PHARMACEUTICALS, INC. valued at approximately $1.84M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/12/2026ACC: 0001959173-26-000257
Officer· Chief Development Officer
Since Nov 2020
61K
Shares to sell
$1.84M
Approx. market value
10K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Convertible Note
Cash
6/30/2014
10KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/30/2014 | Convertible Note Cash | 10K | — |
| Total | 10K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
51K
Market value
$1.55M
12/19/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
10K
Market value
$283.4K
1/12/2026
Total
Units
61K
Value
$1.84M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/19/2025 | 51K | $1.55M | — | Completed |
| Planned — Approximate Date | ||||
1/12/2026 | 10K | $283.4K | NASDAQ | Planned |
| Total | 61K | $1.84M | ||